 Jonathan Kurche
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 9 | 2024 | 505 | 2.320 |
Why?
| | Mucin-5B | 6 | 2024 | 183 | 2.030 |
Why?
| | Interleukin-6 | 2 | 2022 | 675 | 0.790 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 54 | 0.650 |
Why?
| | Cysts | 1 | 2019 | 93 | 0.630 |
Why?
| | Bleomycin | 4 | 2023 | 228 | 0.550 |
Why?
| | Phenotype | 1 | 2024 | 2812 | 0.550 |
Why?
| | OX40 Ligand | 2 | 2011 | 10 | 0.460 |
Why?
| | Dendritic Cells | 3 | 2011 | 436 | 0.460 |
Why?
| | Interferon Type I | 2 | 2011 | 128 | 0.450 |
Why?
| | Receptor, Interferon alpha-beta | 2 | 2011 | 23 | 0.420 |
Why?
| | Membrane Glycoproteins | 2 | 2011 | 429 | 0.410 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1197 | 0.410 |
Why?
| | Tumor Necrosis Factors | 1 | 2011 | 9 | 0.400 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 916 | 0.380 |
Why?
| | CD27 Ligand | 1 | 2010 | 9 | 0.360 |
Why?
| | T-Lymphocyte Subsets | 1 | 2011 | 384 | 0.330 |
Why?
| | Pulmonary Fibrosis | 2 | 2022 | 322 | 0.320 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2011 | 689 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2011 | 965 | 0.300 |
Why?
| | Lymphocyte Activation | 1 | 2011 | 1044 | 0.300 |
Why?
| | Lung Diseases, Interstitial | 2 | 2021 | 507 | 0.260 |
Why?
| | Mice | 9 | 2023 | 14916 | 0.250 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2023 | 23 | 0.220 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.200 |
Why?
| | Respiratory Mucosa | 2 | 2021 | 251 | 0.190 |
Why?
| | Animals | 11 | 2023 | 31761 | 0.190 |
Why?
| | Mice, Transgenic | 2 | 2019 | 1951 | 0.190 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2021 | 58 | 0.190 |
Why?
| | Cell Communication | 1 | 2022 | 279 | 0.180 |
Why?
| | Ligands | 1 | 2022 | 564 | 0.180 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 86 | 0.170 |
Why?
| | Keratin-15 | 1 | 2019 | 13 | 0.170 |
Why?
| | Colloids | 1 | 2019 | 56 | 0.160 |
Why?
| | Aged | 5 | 2024 | 19094 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 71 | 0.160 |
Why?
| | Promoter Regions, Genetic | 1 | 2022 | 1133 | 0.150 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 139 | 0.150 |
Why?
| | Mice, Knockout | 4 | 2011 | 2582 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 718 | 0.140 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.140 |
Why?
| | RNA | 1 | 2022 | 810 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2016 | 41 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2099 | 0.130 |
Why?
| | Cholestyramine Resin | 1 | 2015 | 7 | 0.130 |
Why?
| | Hemothorax | 1 | 2015 | 8 | 0.130 |
Why?
| | Isoxazoles | 1 | 2015 | 52 | 0.130 |
Why?
| | Pericardial Effusion | 1 | 2015 | 21 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2321 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1846 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2011 | 3890 | 0.120 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 71 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2011 | 4710 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1521 | 0.120 |
Why?
| | Humans | 13 | 2024 | 114756 | 0.110 |
Why?
| | Pulmonary Alveoli | 1 | 2016 | 372 | 0.110 |
Why?
| | Shock, Septic | 1 | 2015 | 185 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1319 | 0.110 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 225 | 0.110 |
Why?
| | Antirheumatic Agents | 1 | 2015 | 255 | 0.110 |
Why?
| | Radiation Chimera | 1 | 2011 | 31 | 0.100 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 75 | 0.100 |
Why?
| | Cross-Priming | 1 | 2011 | 19 | 0.100 |
Why?
| | Toll-Like Receptor 7 | 1 | 2011 | 35 | 0.100 |
Why?
| | Vaccinia virus | 1 | 2010 | 28 | 0.090 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2010 | 27 | 0.090 |
Why?
| | Female | 6 | 2024 | 59507 | 0.090 |
Why?
| | Antigen Presentation | 1 | 2011 | 189 | 0.090 |
Why?
| | Signal Transduction | 3 | 2011 | 4521 | 0.090 |
Why?
| | Male | 6 | 2024 | 55579 | 0.080 |
Why?
| | CD40 Antigens | 1 | 2010 | 82 | 0.080 |
Why?
| | Toll-Like Receptors | 1 | 2010 | 166 | 0.080 |
Why?
| | Listeria monocytogenes | 1 | 2010 | 111 | 0.080 |
Why?
| | Lung | 4 | 2023 | 3546 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 927 | 0.080 |
Why?
| | Immunization | 1 | 2010 | 401 | 0.070 |
Why?
| | Vaccines | 1 | 2012 | 375 | 0.070 |
Why?
| | B7-2 Antigen | 1 | 2007 | 25 | 0.070 |
Why?
| | B7-1 Antigen | 1 | 2007 | 54 | 0.070 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 66 | 0.070 |
Why?
| | Middle Aged | 2 | 2024 | 26757 | 0.070 |
Why?
| | Stroke | 1 | 2015 | 1019 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2010 | 1086 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2007 | 328 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1745 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2007 | 342 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2B | 1 | 2023 | 5 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2023 | 91 | 0.050 |
Why?
| | Global Burden of Disease | 1 | 2021 | 15 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 453 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 297 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2021 | 101 | 0.050 |
Why?
| | Heart Transplantation | 1 | 2007 | 667 | 0.050 |
Why?
| | A549 Cells | 1 | 2021 | 51 | 0.050 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 30 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 51 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 152 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 173 | 0.040 |
Why?
| | Global Health | 1 | 2021 | 288 | 0.040 |
Why?
| | Lung Injury | 1 | 2021 | 197 | 0.040 |
Why?
| | Transcriptome | 1 | 2023 | 727 | 0.040 |
Why?
| | RNA Polymerase II | 1 | 2021 | 285 | 0.040 |
Why?
| | Models, Genetic | 1 | 2021 | 565 | 0.040 |
Why?
| | Binding Sites | 1 | 2021 | 1176 | 0.040 |
Why?
| | Chromatin | 1 | 2021 | 428 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 521 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2022 | 955 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1420 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 66 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2312 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2639 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 1892 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2012 | 42 | 0.030 |
Why?
| | Immunity, Humoral | 1 | 2012 | 112 | 0.020 |
Why?
| | Receptors, Interleukin-12 | 1 | 2011 | 6 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 90 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2012 | 248 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6350 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 8627 | 0.020 |
Why?
| | Transplantation, Heterotopic | 1 | 2007 | 16 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 171 | 0.020 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 152 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2269 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2007 | 386 | 0.020 |
Why?
| | Spleen | 1 | 2007 | 484 | 0.020 |
Why?
| | Graft Survival | 1 | 2007 | 452 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1151 | 0.010 |
Why?
| | Graft Rejection | 1 | 2007 | 516 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 463 | 0.010 |
Why?
| | Myocardium | 1 | 2007 | 908 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2015 | 9089 | 0.010 |
Why?
| | Adult | 1 | 2020 | 30548 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 6124 | 0.010 |
Why?
|
|
Kurche's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|